Randomized, Open-Label Study of the BRIA-IMT Regimen and Check Point Inhibitor vs Physician�s Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)

Phase

Phase III Clinical Trial

Trial Number

06072612

Trial Status

OPEN